'Individualized' therapy for the brain targets specific gene mutations causing dementia, ALS
Scientists have developed new drugs that ? at least in a laboratory dish ? appear to halt the brain-destroying impact of a genetic mutation at work in some forms of two incurable diseases, amyotrophic lateral sclerosis (ALS) and dementia.
View full story